Please login to the form below

Not currently logged in
Email:
Password:

ledipasvir/sofosbuvir

This page shows the latest ledipasvir/sofosbuvir news and features for those working in and with pharma, biotech and healthcare.

AbbVie sues NHS England over hep C procurement

AbbVie sues NHS England over hep C procurement

The plan was only made possible by enormous strides in the treatment of HCV and in particular new directly-acting antiviral drugs – pioneered by Gilead Sciences with its Sovaldi (sofosbuvir) and ... treatment – as well as follow-up combinations such

Latest news

More from news
Approximately 1 fully matching, plus 50 partially matching documents found.

Latest Intelligence

  • AbbVie: New firm, new thinking AbbVie: New firm, new thinking

    Gilead Sciences has emerged as the leader in this field with Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir), both of which have already made billions of dollars.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics